Yahoo
Istanbul - Delayed Quote TRY

Hektas Ticaret T.A.S. (HEKTS.IS)

1.6000 +0.0200 (+1.27%)
At close: October 30 at 6:09:27 PM GMT+3
Chart Range Bar
Loading chart for HEKTS.IS
  • Previous Close 1.5800
  • Open 1.5800
  • Bid 1.6100 x --
  • Ask 1.6200 x --
  • Day's Range 1.5700 - 1.7300
  • 52 Week Range 1.5700 - 5.1300
  • Volume 370,290,097
  • Avg. Volume 264,445,600
  • Market Cap (intraday) 14.611B
  • Beta (5Y Monthly) -0.16
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5800
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Dec 2, 2019
  • 1y Target Est 4.30

Hektas Ticaret T.A.S. manufactures, imports, and markets agricultural products, fertilizers and veterinary medicines in Turkey. The company's crop protection products include fungicides, herbicides, insecticides, acaricides, fumigants and nemathists, harvesting aids and plant growth regulators, winter struggle medicines and summer oils, spreads-adhesives, biological products, and feromons. It also offers smart base, leaf, pure, and fertilizers; organominerals; drip irrigation; biological preparation; and other plant nutrition products. In addition, the company provides ruminant, poultry, and pet products, as well as environmental health and seeds products. Hektas Ticaret T.A.S. was incorporated in 1956 and is headquartered in Gebze, Turkey.

hektas.com.tr

559

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .

YTD Return

HEKTS.IS
47.71%
BIST 100 (XU100.IS)
4.46%

1-Year Return

HEKTS.IS
53.89%
BIST 100 (XU100.IS)
0.72%

3-Year Return

HEKTS.IS
92.94%
BIST 100 (XU100.IS)
39.50%

5-Year Return

HEKTS.IS
36.40%
BIST 100 (XU100.IS)
606.94%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY24
Revenue 1.14B
Earnings -755.79M
Profit Margin -66.05%

Q4

FY19

Q1

FY20

Q3

FY24

Q4

FY24

-500M
0
500M
1B
-60.0%
-40.0%
-20.0%
0.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

4.30
4.30 Average
1.6000 Current
4.30 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -78.66%

  • Return on Assets (ttm)

    -4.50%

  • Return on Equity (ttm)

    -28.12%

  • Revenue (ttm)

    5.73B

  • Net Income Avi to Common (ttm)

    -4.51B

  • Diluted EPS (ttm)

    -0.5800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.96B

  • Total Debt/Equity (mrq)

    79.79%

  • Levered Free Cash Flow (ttm)

    -931.7M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: